Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Contact Information
Affiliated Doctors
Creighton University Medical Center Cancer Center is an important branch of the Creighton University Medical School. The Medical School has been serving Nebraska residents with quality care for over 110 years in Omaha. Its mission is to provide students, physicians and the public with advanced medical knowledge and excellence in education. For patients, the goal is quality medical care. To accomplish these goals, the Medical Center views all aspects of treatment as their opportunity to improve the human condition.
Quality of life for persons facing a battle with cancer is enhanced by research efforts at this cancer center. With funding from the National Institutes of Health, research faculty members at the center are in the process of developing new treatment programs for cancer patients. Additional funding by the American Cancer Society, Nebraska Smoking & Tobacco Funds, and the Susan G. Komen Breast Cancer Foundation allows Creighton University Medical Center researchers the ability to combine their knowledge with that of radiation oncologists and other expert medical professionals for work on CUMC cancer research projects.
Improving treatments and lifestyles for cancer patients is a constant goal for university scientists. Physicians, oncologists and other medical personnel from the community gain valuable knowledge from CUMC research about new treatment procedures, testing and therapies to use in their service to local cancer patients.
A special interest in external agents like tobacco, radiation and chemicals that cause cancer is one area for current CUMC research studies. The American Cancer Society believes that early diagnosis and better treatment procedures will increase survival rates in cancer patients. Genetic and hormonal factors, mutations that are inherited, and other causes of cancer are being studied with the expectation that a cure may result from this research.
Creighton University attracts nationally known surgeons, oncologists and researchers who are developing new technological advances for treatment of rare cancers and hereditary cancers. Many types of cancer care are offered here, along with cardiac care, neurology, neonatal care and medical specialties. CUMC is a leader in new medical treatments such as minimally invasive surgery.
Cancer patients who have hard-to-treat cancers, like mesothelioma, may wish to travel here for specialized cancer treatment. The CUMC team of experts in research, surgery and cancer medicine is innovative in their treatment methods, offering the latest state-of-the-art pharmaceuticals and clinical trials for difficult types of cancer. The cancer center offers innovative treatment for three special areas of cancer disease: breast cancer, peritoneal neoplastic diseases, and skin cancers. They also treat solid organ tumors of the colon, pancreas and appendix.
Patient care is very important to everyone working with Creighton University Medical Center Cancer Center. Residents of Nebraska and other states come here for care that puts their needs first. Dealing with cancer of any type, especially hard-to-treat cancers like mesothelioma, puts a lot of physical and mental stress on the patient. Making lives better through compassionate care can also work wonders for treatment success. Creighton Medical Center physicians have experience with all types of cancer; Patients need not worry about the medical expertise of persons handling their case.
Support groups and aftercare are continuing cares issues for those with cancer and their families. Education about cancer and recommended treatments are important support issues at Creighton. Making sure that patients understand all they need to know about their diagnosis, treatment and care adds to overall successful cancer recovery possibilities.